'The University of Alabama at Birmingham recently announced a collaboration with pharmaceutical behemoth vaccine producer Merck, to perform Gardasil 9 HPV vaccine trials on postpartum mothers between the ages of 16 and 26, immediately after having their children at the UAB hospital.
The researchers somehow believe not enough people are being vaccinated for HPV, and the desired outcome of the study is officially to get more young women vaccinated.
According to Vaccine Impact:
Merck and UAB want to test the vaccine on 16 to 26 year old postpartum mothers because “the immune response in young women is less robust than in adolescents,” and because “no studies have examined immunogenicity in postpartum women specifically.”
Therefore, 16 to 26 year old young mothers who have just given birth at the UAB hospital will become test subjects of the Gardasil 9 vaccine.
The study is scheduled to start on June 1, 2018.
The “Responsible Party” who apparently designed the study at UAB is Professor Warner Huh.
The contact person for the clinical vaccine trials is Sarah Dilley, MD 205-934-2749 [email protected] (Source.)
One might be able to construct an argument solid enough to hold up in court, for the fact that the HPV vaccine Merck produces is the most dangerous vaccine on the market, whether it is Cervarix, Gardasil 9, or the other variations of the HPV vaccine that are all very similar.
Here’s an oft-summarized breakdown of the evidence.'
Read more: Merck Will Give Young Mothers The Most Dangerous Vaccine Of All, Trial